Trial Profile
A retrospective chart review of platinum-gemcitabine-bevacizumab in patients with platinum-resistant/refractory ovarian cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jul 2018
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Gemcitabine (Primary) ; Platinum complexes (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 22 Jul 2018 New trial record